| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $3.29B | +6.9% |
| Cost of Revenue | $1.70B | +3.3% |
| R&D Expense | $62.7M | +6.5% |
| SG&A Expense | $205.7M | -1.7% |
| Operating Income | $247.4M | +331.6% |
| Pre-tax Income | $128.4M | +525.0% |
| Income Tax | -$49.4M | -131.7% |
| Net Income | $173.7M | +193.4% |
| EPS (Basic) | $6.64 |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $203.8M | +56.4% |
| Short-term Investments | $4.5M | -88.3% |
| Accounts Receivable | $64.6M | -4.1% |
| Inventory | $97.0M | -10.0% |
| Current Assets | $458.0M | +3.8% |
| Total Assets | $1.89B | +2.0% |
| Current Liabilities | $664.0M | +2.9% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $350.7M | +169.2% |
| Capital Expenditures | $54.9M | +2.1% |
| Investing Cash Flow | -$54.6M | +47.3% |
| Financing Cash Flow | -$222.6M | -25.7% |
| Free Cash Flow | $295.8M | +286.6% |
| +193.8% |
| EPS (Diluted) | $6.43 | +190.8% |
| Long-term Debt |
| $1.59B |
| -2.2% |
| Total Liabilities | $2.42B | -1.9% |
| Stockholders' Equity | -$550.1M | +11.7% |